Application of Metabolomics in Osteoporosis Research

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Dec 1

PMID 36452325

Authors

Zhenyu Zhao

Zhengwei Cai

Aopan Chen

Ming Cai

Kai Yang

Affiliations

Soon will be listed here.

Abstract

Osteoporosis (OP) is a systemic disease characterized by bone metabolism imbalance and bone microstructure destruction, which causes serious social and economic burden. At present, the diagnosis and treatment of OP mainly rely on imaging combined with drugs. However, the existing pathogenic mechanisms, diagnosis and treatment strategies for OP are not clear and effective enough, and the disease progression that cannot reflect OP further restricts its effective treatment. The application of metabolomics has facilitated the study of OP, further exploring the mechanism and behavior of bone cells, prevention, and treatment of the disease from various metabolic perspectives, finally realizing the possibility of a holistic approach. In this review, we focus on the application of metabolomics in OP research, especially the newer systematic application of metabolomics and treatment with herbal medicine and their extracts. In addition, the prospects of clinical transformation in related fields are also discussed. The aim of this study is to highlight the use of metabolomics in OP research, especially in exploring the pathogenesis of OP and the therapeutic mechanisms of natural herbal medicine, for the benefit of interdisciplinary researchers including clinicians, biologists, and materials engineers.

Citing Articles

Combining untargeted and targeted metabolomic profiling reveals principal differences between osteopenia, Osteoporosis and healthy controls.

Tan B, Cheng Y, Li J, Zheng Y, Xiao C, Guo H Aging Clin Exp Res. 2025; 37(1):28.

PMID: 39833609 PMC: 11746959. DOI: 10.1007/s40520-024-02923-3.

Genetic Engineered Ultrasound-Triggered Injectable Hydrogels for Promoting Bone Reconstruction.

Zhao Z, Ruan H, Chen A, Xiong W, Zhang M, Cai M Research (Wash D C). 2025; 6():0221.

PMID: 39830009 PMC: 11740919. DOI: 10.34133/research.0221.

From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches.

Li Q, Wang J, Zhao C Biomedicines. 2024; 12(10).

PMID: 39457701 PMC: 11505085. DOI: 10.3390/biomedicines12102389.

Unraveling the Evolutionary Diet Mismatch and Its Contribution to the Deterioration of Body Composition.

Assaf S, Park J, Chowdhry N, Ganapuram M, Mattathil S, Alakeel R Metabolites. 2024; 14(7).

PMID: 39057702 PMC: 11279030. DOI: 10.3390/metabo14070379.

BRD4 facilitates osteogenic differentiation of human bone marrow mesenchymal stem cells through WNT4/NF-κB pathway.

Ning T, Guo H, Ma M, Zha Z J Orthop Surg Res. 2023; 18(1):876.

PMID: 37980502 PMC: 10656925. DOI: 10.1186/s13018-023-04335-x.

References

Zhang M, Wang Y, Zhang Q, Wang C, Zhang D, Wan J . UPLC/Q-TOF-MS-based metabolomics study of the anti-osteoporosis effects of Achyranthes bidentata polysaccharides in ovariectomized rats. Int J Biol Macromol. 2018; 112:433-441. DOI: 10.1016/j.ijbiomac.2018.01.204. View

Wang M, Yang X, Wang F, Li R, Ning H, Na L . Calcium-deficiency assessment and biomarker identification by an integrated urinary metabonomics analysis. BMC Med. 2013; 11:86. PMC: 3652781. DOI: 10.1186/1741-7015-11-86. View

Shen C, Mo H, Dunn D, Watkins B . Tocotrienol Supplementation Led to Higher Serum Levels of Lysophospholipids but Lower Acylcarnitines in Postmenopausal Women: A Randomized Double-Blinded Placebo-Controlled Clinical Trial. Front Nutr. 2022; 8:766711. PMC: 8740329. DOI: 10.3389/fnut.2021.766711. View

Baba M, Endoh M, Ma W, Toyama H, Hirayama A, Nishikawa K . Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation. J Bone Miner Res. 2018; 33(10):1785-1798. PMC: 6220829. DOI: 10.1002/jbmr.3477. View

Muthubharathi B, Gowripriya T, Balamurugan K . Metabolomics: small molecules that matter more. Mol Omics. 2021; 17(2):210-229. DOI: 10.1039/d0mo00176g. View

Li X, Wang Y, Gao M, Bao B, Cao Y, Cheng F . Metabolomics-driven of relationships among kidney, bone marrow and bone of rats with postmenopausal osteoporosis. Bone. 2021; 156:116306. DOI: 10.1016/j.bone.2021.116306. View

Porter F, Herman G . Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res. 2010; 52(1):6-34. PMC: 2999931. DOI: 10.1194/jlr.R009548. View

Wishart D . Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016; 15(7):473-84. DOI: 10.1038/nrd.2016.32. View

Wang Y, Deng P, Liu Y, Wu Y, Chen Y, Guo Y . Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations. Nat Commun. 2020; 11(1):5596. PMC: 7645772. DOI: 10.1038/s41467-020-19360-1. View

10.

Tao Y, Huang S, Yan J, Li W, Cai B . Integrated metallomic and metabolomic profiling of plasma and tissues provides deep insights into the protective effect of raw and salt-processed Achyranthes bidentata Blume extract in ovariectomia rats. J Ethnopharmacol. 2019; 234:85-95. DOI: 10.1016/j.jep.2019.01.033. View

11.

Wang N, Zheng L, Qian J, Wang M, Li L, Huang Y . Salivary microbiota of periodontitis aggravates bone loss in ovariectomized rats. Front Cell Infect Microbiol. 2022; 12:983608. PMC: 9411930. DOI: 10.3389/fcimb.2022.983608. View

12.

Qi H, Bao J, An G, Ouyang G, Zhang P, Wang C . Association between the metabolome and bone mineral density in pre- and post-menopausal Chinese women using GC-MS. Mol Biosyst. 2016; 12(7):2265-75. DOI: 10.1039/c6mb00181e. View

13.

Ling C, Miao Z, Xiao M, Zhou H, Jiang Z, Fu Y . The Association of Gut Microbiota With Osteoporosis Is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort. J Clin Endocrinol Metab. 2021; 106(10):e3852-e3864. DOI: 10.1210/clinem/dgab492. View

14.

Lee M, Kim H, Singh D, Yeo S, Baek S, Park Y . Metabolite Profiling Reveals the Effect of Dietary Rubus coreanus Vinegar on Ovariectomy-Induced Osteoporosis in a Rat Model. Molecules. 2016; 21(2):149. PMC: 6273122. DOI: 10.3390/molecules21020149. View

15.

Varri M, Niskanen L, Tuomainen T, Honkanen R, Kroger H, Tuppurainen M . Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study. Vasc Health Risk Manag. 2020; 16:515-524. PMC: 7719314. DOI: 10.2147/VHRM.S279028. View

16.

Wang Z, Bian L, Mo C, Shen H, Zhao L, Su K . Quantification of aminobutyric acids and their clinical applications as biomarkers for osteoporosis. Commun Biol. 2020; 3(1):39. PMC: 6976694. DOI: 10.1038/s42003-020-0766-y. View

17.

Ma Y, Hou Z, Li Y, Zheng B, Wang J, Wang W . Unveiling the Pharmacological Mechanisms of Eleutheroside E Against Postmenopausal Osteoporosis Through UPLC-Q/TOF-MS-Based Metabolomics. Front Pharmacol. 2020; 11:1316. PMC: 7479840. DOI: 10.3389/fphar.2020.01316. View

18.

Gao M, Tang X, Zhang F, Yao Z, Yao X, Dai Y . Biotransformation and metabolic profile of Xian-Ling-Gu-Bao capsule, a traditional Chinese medicine prescription, with rat intestinal microflora by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass.... Biomed Chromatogr. 2017; 32(4). DOI: 10.1002/bmc.4160. View

19.

Wishart D, Cheng L, Copie V, Edison A, Eghbalnia H, Hoch J . NMR and Metabolomics-A Roadmap for the Future. Metabolites. 2022; 12(8). PMC: 9394421. DOI: 10.3390/metabo12080678. View

20.

Arceo-Mendoza R, Camacho P . Postmenopausal Osteoporosis: Latest Guidelines. Endocrinol Metab Clin North Am. 2021; 50(2):167-178. DOI: 10.1016/j.ecl.2021.03.009. View